ARK Genomic Revolution ETF
ARKG
ARKG
207 hedge funds and large institutions have $525M invested in ARK Genomic Revolution ETF in 2025 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 39 increasing their positions, 66 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
207
Holders Change
-3
Holders Change %
-1.43%
% of All Funds
2.78%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
34
Increased
39
Reduced
66
Closed
32
Calls
$107M
Puts
$116M
Net Calls
-$8.28M
Net Calls Change
-$21M
Top Buyers
| 1 |
JPMorgan Chase & Co
New York
|
$106M |
| 2 |
UBS Group
Zurich,
Switzerland
|
$32.9M |
| 3 |
Citadel Advisors
Miami,
Florida
|
$9.29M |
| 4 |
Wells Fargo
San Francisco,
California
|
$26.5M |
| 5 |
Two Sigma Investments
New York
|
$3.05M |
Top Sellers
| 1 |
Citigroup
New York
|
$16.3M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
$10.7M |
| 3 |
Morgan Stanley
New York
|
$51.8M |
| 4 |
BNP Paribas Financial Markets
Paris,
France
|
$64.4M |
| 5 |
SG Americas Securities
New York
|
$766K |
